
|Articles|April 1, 2003
Hair Removal Duet
San Francisco -- Topical eflornithine hydrochloride 13.9 percent cream (Vaniqa) can be used safely by patients undergoing laser hair removal and may have added value for improving the response to photoepilation, especially early on, according to results of a double-blinded study presented by Stacy R. Smith, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Lebrikizumab Earns FDA Approval for Less Frequent, Every-8-Week Maintenance Dosing in AD
3
The Misuse and Overuse of the Word “Robust” in Dermatology
4
Christopher Bunick, MD, PhD, on Bemotrizinol Approval and Its Role in US Sun Protection
5














